C137H152Cl6N30O13 — CID 159176878
azetidin-1-yl-[1-[4-[bis(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-4-yl]methanone;[1-[4-(1,3-benzodioxol-5-ylmethyl)piperazine-1-carbonyl]pyrazol-4-yl]-piperidin-1-ylmethanone;[1-[4-[bis(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-4-yl]-morpholin-4-ylmethanone;[1-[4-[bis(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-4-yl]-piperidin-1-ylmethanone;[4-[(2-methyl-4-phenylphenyl)methyl]piperazin-1-yl]-(4-methylpyrazol-1-yl)methanone;(4-methylpyrazol-1-yl)-[4-(pyrimidin-5-ylmethyl)piperazin-1-yl]methanone (PubChem CID 159176878) has the molecular formula C137H152Cl6N30O13 and a molecular weight of 2639.64 g/mol. Its IUPAC name is azetidin-1-yl-[1-[4-[bis(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-4-yl]methanone;[1-[4-(1,3-benzodioxol-5-ylmethyl)piperazine-1-carbonyl]pyrazol-4-yl]-piperidin-1-ylmethanone;[1-[4-[bis(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-4-yl]-morpholin-4-ylmethanone;[1-[4-[bis(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-4-yl]-piperidin-1-ylmethanone;[4-[(2-methyl-4-phenylphenyl)methyl]piperazin-1-yl]-(4-methylpyrazol-1-yl)methanone;(4-methylpyrazol-1-yl)-[4-(pyrimidin-5-ylmethyl)piperazin-1-yl]methanone.
| Compound Name | azetidin-1-yl-[1-[4-[bis(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-4-yl]methanone;[1-[4-(1,3-benzodioxol-5-ylmethyl)piperazine-1-carbonyl]pyrazol-4-yl]-piperidin-1-ylmethanone;[1-[4-[bis(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-4-yl]-morpholin-4-ylmethanone;[1-[4-[bis(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-4-yl]-piperidin-1-ylmethanone;[4-[(2-methyl-4-phenylphenyl)methyl]piperazin-1-yl]-(4-methylpyrazol-1-yl)methanone;(4-methylpyrazol-1-yl)-[4-(pyrimidin-5-ylmethyl)piperazin-1-yl]methanone |
|---|---|
| PubChem CID | 159176878 |
| Molecular Formula | C137H152Cl6N30O13 |
| Molecular Weight | 2639.64 g/mol |
| Exact Mass | 2635.03 |
| IUPAC Name | azetidin-1-yl-[1-[4-[bis(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-4-yl]methanone;[1-[4-(1,3-benzodioxol-5-ylmethyl)piperazine-1-carbonyl]pyrazol-4-yl]-piperidin-1-ylmethanone;[1-[4-[bis(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-4-yl]-morpholin-4-ylmethanone;[1-[4-[bis(4-chlorophenyl)methyl]piperazine-1-carbonyl]pyrazol-4-yl]-piperidin-1-ylmethanone;[4-[(2-methyl-4-phenylphenyl)methyl]piperazin-1-yl]-(4-methylpyrazol-1-yl)methanone;(4-methylpyrazol-1-yl)-[4-(pyrimidin-5-ylmethyl)piperazin-1-yl]methanone |
| SMILES | Cc1cnn(C(=O)N2CCN(Cc3ccc(-c4ccccc4)cc3C)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3cncnc3)CC2)c1.O=C(c1cnn(C(=O)N2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)c1)N1CCC1.O=C(c1cnn(C(=O)N2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)c1)N1CCCCC1.O=C(c1cnn(C(=O)N2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)c1)N1CCOCC1.O=C(c1cnn(C(=O)N2CCN(Cc3ccc4c(c3)OCO4)CC2)c1)N1CCCCC1 |
| InChI | InChI=1S/C27H29Cl2N5O2.C26H27Cl2N5O3.C25H25Cl2N5O2.C23H26N4O.C22H27N5O4.C14H18N6O/c28-23-8-4-20(5-9-23)25(21-6-10-24(29)11-7-21)31-14-16-33(17-15-31)27(36)34-19-22(18-30-34)26(35)32-12-2-1-3-13-32;27-22-5-1-19(2-6-22)24(20-3-7-23(28)8-4-20)30-9-11-32(12-10-30)26(35)33-18-21(17-29-33)25(34)31-13-15-36-16-14-31;26-21-6-2-18(3-7-21)23(19-4-8-22(27)9-5-19)29-12-14-31(15-13-29)25(34)32-17-20(16-28-32)24(33)30-10-1-11-30;1-18-15-24-27(16-18)23(28)26-12-10-25(11-13-26)17-22-9-8-21(14-19(22)2)20-6-4-3-5-7-20;28-21(25-6-2-1-3-7-25)18-13-23-27(15-18)22(29)26-10-8-24(9-11-26)14-17-4-5-19-20(12-17)31-16-30-19;1-12-6-17-20(9-12)14(21)19-4-2-18(3-5-19)10-13-7-15-11-16-8-13/h4-11,18-19,25H,1-3,12-17H2;1-8,17-18,24H,9-16H2;2-9,16-17,23H,1,10-15H2;3-9,14-16H,10-13,17H2,1-2H3;4-5,12-13,15H,1-3,6-11,14,16H2;6-9,11H,2-5,10H2,1H3 |
| InChIKey | KMJVLJMPILAYCJ-UHFFFAOYSA-N |
| XLogP | 20.38 |
| TPSA | 382.93 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 186 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2639.64 |
| LogP ≤ 5 | 20.38 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 33 |